GenSight Biologics

GenSight Biologics

GenSight Biologics

Type
B2c
Founded
2013
Raised
$25.3M
Follow us
Alexa global traffic share
Latest funding
€22,500,000
Post-IPO equity - 2017
Team Size
10+
Employees
Location
Headquarters
€22,500,000 Post-IPO equity
morningstar

GenSight Biologics Successfully Raises €22.5 Million from Leading Investors in the US and Europe